Ropes & Gray advised Immucor in its investment in Palo Alto, Calif.-based Sirona Genomics. Under the terms of the deal, which was announced October 3, Immucor will provide funding to support the commercialization of Sirona’s human leukocyte antigen (HLA) typing sample preparation and bioinformatics offering using next generation sequencing instruments. Immucor, a TPG portfolio company, is a leader in the transfusion and transplantation diagnostics industry. Financial terms were not disclosed.
The Ropes & Gray team included private equity partner Neill Jakobe (Chicago), tax partner Aaron Harsh (Boston), finance partner Alexander Zeltser (New York), and health care counsel Alison Fethke (Chicago).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.